Anti-CEA x Anti-TNFα Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CEA and anti-TNFα parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget cytokine (TNFα) to tumor cells. It is designed for the research of Breast cancer; Ovary cancer; Colon cancer; Lung cancer therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY